Raymond James Downgrades Leap Therapeutics to Market Perform

Raymond James downgrades Leap Therapeutics (NASDAQ:LPTX) from Outperform to Market Perform.

Benzinga · 11/15/2019 11:34

Raymond James downgrades Leap Therapeutics (NASDAQ:LPTX) from Outperform to Market Perform.